Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

Axitinib

9a5d3000-004e-5d6a-a2c7-6a96e9e9ff11 · FDA Approved · targets FLT1_VEGFR1, KDR_VEGFR2, FLT4_VEGFR3

Axitinib

MeasuredReference

Axitinib targets AURORA_A, ABL1, TNIK. Strongest hallmark effect: tumor promoting inflammation.

Top hallmarks

  • tumor promoting inflammation3.8k
  • evading apoptosis3.3k
  • proliferation3.1k

Top pathways disrupted

  • pi3k akt mtor signaling8.2k
  • apical junction7.9k
  • allograft rejection7.4k

Resistance landscape — Axitinib

MeasuredReference

10 known oncogenic variants exist on Axitinib's top targets — see detail for inhibition impact.

Open in new tab